drugset / Trial / NCT02235259
Efficacy and Safety of XG-104 for the Treatment of Dry Eye
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of this study is to assess the safety and efficacy of XG-104 Ophthalmic Solution compared to placebo for the treatment of the signs and symptoms of dry eye after a 4 week Three Times a Day (TID) treatment period
Timeline
- Start
- 2014-09
- Primary completion
- 2015-02
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | XG-104 | Unknown | — | Other |